Correspondence to Dr Chanu Rhee, Department of Population Medicine, Harvard Medical School/Harvard Pilgrim Health Care Institute, Boston, MA 02215, USA; crhee{at}bwh.harvard.edu Sepsis, the syndrome ...
Emergency department. A patient with COPD. SpOâ‚‚ is quite low, tachypnea. While thinking, 'I need to increase the oxygen,' a thought crosses my mind. 'If I increase the oxygen for a COPD patient, won't ...
Case Presentation: A 37-year-old man with no known medical history presented to a pharmacy with agitation and severe chest pain radiating to the back. At 16:00, he experienced a witnessed cardiac ...
Acute respiratory distress syndrome (ARDS) is a life-threatening condition characterized by diffuse alveolar damage and severe hypoxemia, with mortality rates remaining high despite advances in ...
The SOFA-2 score included new definitions, new variables, and revised thresholds to categorize the severity of organ dysfunction in critical illness. The updates reflected changes in practice, ...
ABSTRACT: Background: There is a paucity of data on the efficacy of ventilatory strategies in COVID-19-related ARDS. The aim of this study was to describe the effect of positive end-expiratory ...
North-South Syndrome, also known as Harlequin Syndrome or Differential Hypoxia, is a critical condition that can occur in patients on peripheral Veno-Arterial Extracorporeal Membrane Oxygenation (VA ...
ABSTRACT: Importance: The best respiratory support technique to reduce intubation and mortality in patients with respiratory failure due to COVID-19 is controversial. Objective: To determine the ...
Critically ill patients with tuberculosis carry high mortality. Identification of factors associated with mortality in critically ill tuberculosis patients may enable focused treatment. An extensive ...
Despite the fervent scientific effort, a state-of-the art assessment of the different causes of hypoxemia (shunt, ventilation-perfusion mismatch and diffusion limitation) in COVID-19 ARDS is currently ...
Introduction High-flow nasal oxygen (HFNO) use in adults hospitalised with acute respiratory failure (ARF) is increasing. However, evidence to support widespread use of HFNO compared with non-invasive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results